Literature DB >> 21622236

The good, the bad and the ugly. Macrophages/microglia with a focus on myelin repair.

Axinia Doring1, Voon Wee Yong.   

Abstract

A feature of most neurological disorders is demyelination, whereby myelin is lost from axons partly through stripping by macrophages/microglia. Spontaneous remyelination by oligodendrocytes that mature from oligodendrocyte precursor cells occurs following demyelination, even in the chronic inflammatory disorder of the central nervous system, multiple sclerosis. If remyelination does not occur or is prevented, then one consequence besides the loss of saltatory nerve conduction is the degeneration of axons. Thus, promoting remyelination is a desired result. In this article, we review the data that despite a reputation as "bad" factors for CNS wellbeing, including the promotion of neuroinflammation and demyelination, some aspects of macrophages/microglia activity are indeed "good", and can engender repair from the "ugly" phenomenon of demyelination. We discuss factors that help promote the benefits of macrophages/microglia activity for remyelination.

Entities:  

Mesh:

Year:  2011        PMID: 21622236     DOI: 10.2741/191

Source DB:  PubMed          Journal:  Front Biosci (Schol Ed)        ISSN: 1945-0516


  13 in total

Review 1.  The innate immune system in demyelinating disease.

Authors:  Lior Mayo; Francisco J Quintana; Howard L Weiner
Journal:  Immunol Rev       Date:  2012-07       Impact factor: 12.988

Review 2.  Outdoor Ambient Air Pollution and Neurodegenerative Diseases: the Neuroinflammation Hypothesis.

Authors:  Richard L Jayaraj; Eric A Rodriguez; Yi Wang; Michelle L Block
Journal:  Curr Environ Health Rep       Date:  2017-06

3.  Neonatal infraorbital nerve crush-induced CNS synaptic plasticity and functional recovery.

Authors:  Fu-Sun Lo; Shuxin Zhao; Reha S Erzurumlu
Journal:  J Neurophysiol       Date:  2014-01-29       Impact factor: 2.714

4.  Pesticides, microglial NOX2, and Parkinson's disease.

Authors:  Thomas Taetzsch; Michelle L Block
Journal:  J Biochem Mol Toxicol       Date:  2013-01-24       Impact factor: 3.642

5.  Inferring metabolic networks using the Bayesian adaptive graphical lasso with informative priors.

Authors:  Christine Peterson; Marina Vannucci; Cemal Karakas; William Choi; Lihua Ma; Mirjana Maletić-Savatić
Journal:  Stat Interface       Date:  2013-10-01       Impact factor: 0.582

Review 6.  Dendritic cells and multiple sclerosis: disease, tolerance and therapy.

Authors:  Mohammad G Mohammad; Masoud Hassanpour; Vicky W W Tsai; Hui Li; Marc J Ruitenberg; David W Booth; Jordi Serrats; Prue H Hart; Geoffrey P Symonds; Paul E Sawchenko; Samuel N Breit; David A Brown
Journal:  Int J Mol Sci       Date:  2012-12-27       Impact factor: 5.923

7.  Oral administration of the KATP channel opener diazoxide ameliorates disease progression in a murine model of multiple sclerosis.

Authors:  Noemí Virgili; Juan F Espinosa-Parrilla; Pilar Mancera; Andrea Pastén-Zamorano; Javier Gimeno-Bayon; Manuel J Rodríguez; Nicole Mahy; Marco Pugliese
Journal:  J Neuroinflammation       Date:  2011-11-02       Impact factor: 8.322

8.  Extracellular membrane vesicles and immune regulation in the brain.

Authors:  Chiara Cossetti; Jayden A Smith; Nunzio Iraci; Tommaso Leonardi; Clara Alfaro-Cervello; Stefano Pluchino
Journal:  Front Physiol       Date:  2012-05-01       Impact factor: 4.566

Review 9.  Immune responses to non-tumor antigens in the central nervous system.

Authors:  Amanda K Huber; Patrick C Duncker; David N Irani
Journal:  Front Oncol       Date:  2014-11-13       Impact factor: 6.244

10.  TIR-Domain-Containing Adapter-Inducing Interferon-β (TRIF) Is Essential for MPTP-Induced Dopaminergic Neuroprotection via Microglial Cell M1/M2 Modulation.

Authors:  Minghui Shan; Sen Lin; Shurong Li; Yuchen Du; Haixia Zhao; Huarong Hong; Ming Yang; Xi Yang; Yongmei Wu; Liyi Ren; Jiali Peng; Jing Sun; Hongli Zhou; Bingyin Su
Journal:  Front Cell Neurosci       Date:  2017-02-22       Impact factor: 5.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.